104 related articles for article (PubMed ID: 1769132)
1. Naloxone does not modify fenfluramine-induced prolactin increase in obese patients.
Argenio GF; Bernini GP; Vivaldi MS; del Corso C; Santoni R; Franchi F
Clin Endocrinol (Oxf); 1991 Dec; 35(6):505-8. PubMed ID: 1769132
[TBL] [Abstract][Full Text] [Related]
2. Naloxone reduces the fenfluramine-induced prolactin release in man.
Foresta C; Scanelli G; Indino M; Federspil G; Scandellari C
Clin Endocrinol (Oxf); 1985 Apr; 22(4):539-43. PubMed ID: 3987071
[TBL] [Abstract][Full Text] [Related]
3. Effect of fenfluramine on prolactin secretion in obese patients: evidence for serotoninergic regulation of prolactin in man.
Barbieri C; Magnoni V; Rauhe WG; Zanasi S; Caldara R; Ferrari C
Clin Endocrinol (Oxf); 1983 Dec; 19(6):705-10. PubMed ID: 6360431
[TBL] [Abstract][Full Text] [Related]
4. Effects of fenfluramine and ritanserin on prolactin response to insulin-induced hypoglycemia in obese patients: evidence for failure of the serotoninergic system.
Bernini GP; Argenio GF; Vivaldi MS; Del Corso C; Sgrò M; Franchi F; Luisi M
Horm Res; 1989; 31(3):133-7. PubMed ID: 2501208
[TBL] [Abstract][Full Text] [Related]
5. Effect of fenfluramine on prolactin and thyroid-stimulating-hormone response to thyrotropin-releasing-hormone in obese and normal women.
Argenio G; Bernini G; Vivaldi MS; Del Corso C; Monzani F; Baschieri L; Bertolozzi G; Santoni R; Franchi F; Luisi M
Eur J Clin Pharmacol; 1990; 39(1):13-6. PubMed ID: 2125937
[TBL] [Abstract][Full Text] [Related]
6. Effect of fenfluramine on growth hormone and prolactin secretion in obese subjects.
Altomonte L; Zoli A; Alessi F; Ghirlanda G; Manna R; Greco AV
Horm Res; 1987; 27(4):190-4. PubMed ID: 3436616
[TBL] [Abstract][Full Text] [Related]
7. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia.
Larrea F; Sandoval JL; Salinas E; Franco-Rodriguez VA; Méndez I; Ulloa-Aguirre A
Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944
[TBL] [Abstract][Full Text] [Related]
8. Effects of naloxone on prolactin, growth hormone and cortisol response to insulin hypoglycemia in obese subjects.
Papalia D; Lunetta M; Di Mauro M
J Endocrinol Invest; 1989 Dec; 12(11):777-82. PubMed ID: 2693516
[TBL] [Abstract][Full Text] [Related]
9. Evidence for serotoninergic system involvement in opioid control of luteinizing hormone secretion in man.
Foresta C; Mioni R; Scandellari C
Clin Endocrinol (Oxf); 1986 Nov; 25(5):573-8. PubMed ID: 3621624
[TBL] [Abstract][Full Text] [Related]
10. Role of gonadal steroids in the serotoninergic control of prolactin secretion in men.
Foresta C; Indino M; Scandellari C
Clin Endocrinol (Oxf); 1987 May; 26(5):601-7. PubMed ID: 3665121
[TBL] [Abstract][Full Text] [Related]
11. Naloxone inhibits sulpiride-induced hyperprolactinaemia in man.
Bernini GP; Pedrinelli R; Salvetti A; Franchi F; Luisi M
Eur J Clin Invest; 1985 Oct; 15(5):272-5. PubMed ID: 3935458
[TBL] [Abstract][Full Text] [Related]
12. Serotonergic regulation of prolactin and growth hormone secretion in man.
Lewis DA; Sherman BM
Acta Endocrinol (Copenh); 1985 Oct; 110(2):152-7. PubMed ID: 4060968
[TBL] [Abstract][Full Text] [Related]
13. The effects of opioid blockade and GnRH administration upon luteinizing hormone secretion in patients with anorexia nervosa during the stages of weight loss and weight recovery.
García-Rubí E; Vazquez-Alemán D; Mendez JP; Salinas JL; Garza-Flores J; Ponce-de-León S; Perez-Palacios G; Ulloa-Aguirre A
Clin Endocrinol (Oxf); 1992 Dec; 37(6):520-8. PubMed ID: 1286522
[TBL] [Abstract][Full Text] [Related]
14. Naloxone-induced prolactin secretion in women: evidence against a direct prolactin stimulatory effect of endogenous opioids.
Cetel NS; Quigley ME; Yen SS
J Clin Endocrinol Metab; 1985 Jan; 60(1):191-6. PubMed ID: 3964791
[TBL] [Abstract][Full Text] [Related]
15. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study.
Monteleone P; Tortorella A; Borriello R; Cassandro P; Maj M
Biol Psychiatry; 1999 Jun; 45(12):1606-11. PubMed ID: 10376122
[TBL] [Abstract][Full Text] [Related]
16. Serotonin but not dopamine is involved in the naloxone-induced luteinizing hormone release in man.
Foresta C; Scanelli G; Tramarin A; Scandellari C
Fertil Steril; 1985 Mar; 43(3):447-50. PubMed ID: 3979585
[TBL] [Abstract][Full Text] [Related]
17. Opioidergic inhibition of luteinising hormone and prolactin release changes during pregnancy in pony mares.
Aurich C; Aurich JE; Parvizi N
J Endocrinol; 2001 Jun; 169(3):511-8. PubMed ID: 11375121
[TBL] [Abstract][Full Text] [Related]
18. Central serotoninergic stimulation by fenfluramine challenge does not affect plasma thyrotropin-stimulating hormone levels in man.
Coccaro EF; Siever LJ; Kourides IA; Adan F; Campbell G; Davis KL
Neuroendocrinology; 1988 Apr; 47(4):273-6. PubMed ID: 3374753
[TBL] [Abstract][Full Text] [Related]
19. Participation of opioid and serotoninergic systems in prolactin secretion induced by hypothalamic action of estradiol.
Carón RW; Deis RP
Neuroendocrinology; 1996 Aug; 64(2):124-30. PubMed ID: 8857606
[TBL] [Abstract][Full Text] [Related]
20. Depending on the stimulus, central serotoninergic activation by fenfluramine blocks or does not alter growth hormone secretion in man.
Casanueva FF; Villanueva L; Peñalva A; Cabezas-Cerrato J
Neuroendocrinology; 1984 Apr; 38(4):302-8. PubMed ID: 6374488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
